[Homocysteine and cardiovascular disease]

F Skovby1, J Dyerberg, E Nexø

  • 1H:S Rigshospitalet, klinisk genetisk afdeling.

Ugeskrift for Laeger
|April 11, 2001
PubMed

Insights

High homocysteine levels in rare metabolic disorders reduce vascular thrombosis risk. Measuring homocysteine aids screening for unexplained vascular events and potential inborn errors of metabolism.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Genetics

Context:

  • Elevated plasma homocysteine is linked to vascular thromboses, particularly in rare inborn errors of metabolism.
  • Epidemiological studies suggest a correlation between moderately increased homocysteine and ischemic cardiovascular disease.
  • Folic acid and other vitamin supplements can lower plasma homocysteine levels.

Purpose:

  • To evaluate the role of plasma homocysteine in vascular thrombosis risk.
  • To determine the utility of homocysteine measurement in clinical screening.
  • To investigate the association between homocysteine and cardiovascular disease incidence.

Summary:

  • Treatment of severe hyperhomocysteinemia in metabolic disorders decreases vascular thrombosis risk.
  • Ongoing studies are assessing the impact of folic acid and vitamins on cardiovascular disease incidence.
  • Plasma homocysteine measurement is recommended for patients with unexplained or recurrent vascular thromboses.

Impact:

  • Supports the screening of patients with early or frequent vascular thromboses and atypical risk factors.
  • Identifies patients requiring investigation for inborn errors of metabolism when homocysteine exceeds 30 mumol/l.
  • Informs clinical practice regarding homocysteine assessment and its implications for cardiovascular health.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...